Herpes Simplex Type 1 and Type 2 Glycoprotein G-Specific Antibodies, IgG by CIA
In the absence of active lesions, this is the preferred serology test for diagnosing herpes simplex viral infection.
Semi-Quantitative Chemiluminescent Immunoassay
New York DOH Approval Status
Serum separator tube.
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimen. Mark specimens plainly as "acute" or "convalescent."
Plasma or urine. Contaminated, heat-inactivated, hemolyzed, or lipemic specimens.
Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year
|0050292||Herpes Simplex Virus Type 1 Glycoprotein G-Specific Antibody, IgG by CIA||
|0050294||Herpes Simplex Virus Type 2 Glycoprotein G-Specific Antibody, IgG by CIA||
Individuals infected with HSV may not exhibit detectable IgG antibody to type-specific HSV antigens 1 and 2 in the early stages of infection. Detection of antibody presence in these cases may only be possible using a non-type specific screening test.
For CSF, refer to Herpes Simplex Virus Type 1 Glycoprotein G-Specific Antibody, IgG by ELISA, CSF (ARUP test code 0050379) and Herpes Simplex Virus Type 2 Glycoprotein G-Specific Antibody, IgG by ELISA, CSF (ARUP test code 0050359).
|Component Test Code*||Component Chart Name||LOINC|
|0050292||HSV 1 Glycoprotein G Ab, IgG||42337-6|
|0050294||HSV 2 Glycoprotein G Antibody, IgG||42338-4|
- HSV glycoprotein G type 1 and 2
- HSV typing 1 and 2